Journal of Pediatric and Adolescent Gynecology
Volume 16, Issue 1 , Pages 57-60 , February 2003

What's New in the New CDC HIV and STD Guidelines

  • Gale R Burstein, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Gale R. Burstein, MD, MPH, Division of HIV and AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail Stop E-46, Atlanta, GA 30333, USA
  • ,
  • Kenneth V Hunt

References 

  1. Centers for Disease Control and Prevention: Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women. MMWR 2001; 50(No. RR-19)
  2. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines 2002. MMWR 2002; 51(No. RR-6)
  3. Centers for Disease Control and Prevention . HIV Counseling, Testing, and Referral Standards and Guidelines. Atlanta: Department of Health and Human Services, Public Health Service; 1994;
  4. Rosenberg PS, Biggar RJ, Goeder JJ. Declining age at HIV infection in the United States. N Engl J Med. 1994;330(1):789
  5. Kamb ML, Fishbein M, Douglas JM, et al.  Efficacy of risk-reduction counseling and to prevent human immunodeficiency virus and sexually transmitted diseases (a randomized controlled trial). Project RESPECTS Study Group. JAMA. 1998;280:1161
  6. Shain RN, Piper JM, Newton ER, et al.  A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. New Engl J Med. 1999;34:93
  7. O'Donnell C, O'Donnell L, San Doval A, Duran R, Labes K. Reductions in STD infections subsequent to an STD clinic visit (using video-based patient education to supplement provider interactions). Sex Transm Dis. 1998;25:161
  8. Cohen DA, MacKinnon DP, Dent C, Masson HRC, Sullivan E. Group counseling at STD clinics to promote use of condoms. Public Health Rep. 1992;107:727
  9. Connor EM, Sealing RS, Gelber R, et al.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New Engl J Med. 1994;331:1173
  10. Centers for Disease Control and Prevention: U.S. Public Health Service recommendations of human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR 1995; 44(No. RR-11)
  11. Institute of Medicine, National Research Council . Reducing the Odds (Preventing Perinatal Transmission of HIV in the United States). Washington, DC: National Academy Press; 1999;
  12. Centers for Disease Control and Prevention: 1998 Guidelines for the treatment of sexually transmitted diseases. MMWR 1998; 47(No. RR-1)
  13. Centers for Disease Control and Prevention: Recommendations for the prevention and management of Chlamydia trachomatis infections 1993. MMWR 1993; 42(No. RR-12):8
  14. Madico G, Quinn TC, Rompalo A, McKee KT, Gaydos CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol. 1998;36:3205
  15. Burstein GR, Berman SM, Blumer JL, Moran JS. Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents (does benefit outweigh risk?). Clin Infect Dis. 2002;35:5191
  16. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL: A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. New Engl J Med 889; 339:504
  17. Joint United Nations Programme on HIV/AIDS Web site: UNAIDS calls for continued commitment to microbicides. Available: http://www.unaids.org/whatsnew/press/eng/press arc00/durban120700.html. Accessed July 25, 2002

PII: S1083-3188(02)00210-3

Journal of Pediatric and Adolescent Gynecology
Volume 16, Issue 1 , Pages 57-60 , February 2003